With rapid advances in the understanding of the underlying biology and mechanisms of aging, ground-breaking research and technology are coming together to target aging pathways, in a way to prevent, reverse or delay the onset of age-related conditions, and consequently improve heathspan.

The 2nd Longevity Therapeutics 2020 Summit will once again bring together 80+ leading experts in aging-related research, including biotechs, pharma, academics and investors, who are committed to serving worldwide population with innovative drugs to prevent, delay and treat age-related conditions.

Join us in San Francisco and be part of this exciting community – we’ve come to the crossroad to accelerate longevity therapeutics preclinical study into clinic. It’s only through collaborative and open discussions can we tackle challenges and find solutions, particularly in regulatory framework and commercialization.

Make 2020 your year to influence longevity therapeutics drug development!